S2Medical AB (publ) (S2M.ST)
SEK 0.01
(4.55%)
SEK 0.01
(4.55%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 19.74 Million SEK | 8.36% |
| 2022 | 18.22 Million SEK | 21.54% |
| 2021 | 14.99 Million SEK | 76.9% |
| 2020 | 8.47 Million SEK | 51.4% |
| 2019 | 5.59 Million SEK | 1.21% |
| 2018 | 5.53 Million SEK | 45.66% |
| 2017 | 3.79 Million SEK | 3.35% |
| 2016 | 3.67 Million SEK | 6.24% |
| 2015 | 3.45 Million SEK | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 19.35 Million SEK | -1.99% |
| 2024 Q2 | 7.48 Million SEK | -61.34% |
| 2023 Q3 | 18.13 Million SEK | -38.12% |
| 2023 Q1 | 19.71 Million SEK | 8.15% |
| 2023 Q2 | 29.3 Million SEK | 48.65% |
| 2023 FY | 19.74 Million SEK | 8.36% |
| 2023 Q4 | 19.74 Million SEK | 8.93% |
| 2022 Q3 | 16.12 Million SEK | -1.65% |
| 2022 Q2 | 16.39 Million SEK | 1.08% |
| 2022 FY | 18.22 Million SEK | 21.54% |
| 2022 Q4 | 18.22 Million SEK | 13.04% |
| 2022 Q1 | 16.21 Million SEK | 8.15% |
| 2021 Q3 | 3.88 Million SEK | -20.71% |
| 2021 FY | 14.99 Million SEK | 76.9% |
| 2021 Q4 | 14.99 Million SEK | 285.78% |
| 2021 Q2 | 4.9 Million SEK | -2.19% |
| 2021 Q1 | 5.01 Million SEK | -40.87% |
| 2020 FY | 8.47 Million SEK | 51.4% |
| 2020 Q1 | 4.83 Million SEK | -13.71% |
| 2020 Q2 | 4.6 Million SEK | -4.78% |
| 2020 Q3 | 4.34 Million SEK | -5.61% |
| 2020 Q4 | 8.47 Million SEK | 95.23% |
| 2019 Q4 | 5.59 Million SEK | 30.12% |
| 2019 FY | 5.59 Million SEK | 1.21% |
| 2019 Q3 | 4.3 Million SEK | -8.37% |
| 2019 Q2 | 4.69 Million SEK | 6.34% |
| 2019 Q1 | 4.41 Million SEK | -20.18% |
| 2018 Q1 | - SEK | -100.0% |
| 2018 Q4 | 5.53 Million SEK | 0.0% |
| 2018 FY | 5.53 Million SEK | 45.66% |
| 2018 Q2 | 3.44 Million SEK | 0.0% |
| 2017 Q2 | 550 Thousand SEK | 0.0% |
| 2017 FY | 3.79 Million SEK | 3.35% |
| 2017 Q4 | 3.79 Million SEK | 0.01% |
| 2017 Q3 | 3.79 Million SEK | 590.49% |
| 2017 Q1 | 550 Thousand SEK | 0.0% |
| 2016 FY | 3.67 Million SEK | 6.24% |
| 2015 FY | 3.45 Million SEK | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AddLife AB (publ) | 7.78 Billion SEK | 99.746% |
| Biotage AB (publ) | 1.27 Billion SEK | 98.45% |
| Bonesupport Holding AB (publ) | 143.63 Million SEK | 86.251% |
| Doxa AB (publ) | 280.8 Million SEK | 92.967% |
| Elekta AB (publ) | 21.61 Billion SEK | 99.909% |
| iZafe Group AB (publ) | 9.26 Million SEK | -113.254% |
| Ortivus AB (publ) | 55.4 Million SEK | 64.352% |
| Ortivus AB (publ) | 55.4 Million SEK | 64.352% |
| Q-linea AB (publ) | 42.34 Million SEK | 53.355% |
| Synsam AB (publ) | 5.52 Billion SEK | 99.642% |